Fresenius has signed a five-year global contract with Microsoft to enhance IT collaboration and security for its global workforce. Beginning in J ...

You have successfully submitted your enquiry. Someone from our company will respond ASAP Fresenius Kabi Product Partnering is the contract manufacturing platform of Fresenius Kabi, and provides easy ...

Underlying demographic trends and international expansion opportunities should keep help Fresenius Medical Care's dialysis services and related medical product growth in positive territory as the ...

J.P. Morgan analyst David Adlington maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) today and set ...

Kepler Capital analyst Oliver Reinberg maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) on ...

Regulatory ApprovalFormycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® 15.01.2025 / 06:30 CET/CESTThe issuer is solely responsible for the ...

OtulfiTM received a Health Canada Notice of Compliance (NOC) approval on December 30th for both subcutaneous and intravenous formulationsWith this approval, Fresenius Kabi Canada's immunology ...